Connor, Clark & Lunn Investment Management (CC&L)’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $49.9M | Buy |
158,852
+72,286
| +84% | +$22.7M | 0.18% | 107 |
|
2025
Q1 | $26.4M | Buy |
86,566
+21,150
| +32% | +$6.44M | 0.12% | 149 |
|
2024
Q4 | $21.7M | Buy |
65,416
+38,991
| +148% | +$13M | 0.1% | 159 |
|
2024
Q3 | $8.82M | Buy |
26,425
+21,764
| +467% | +$7.26M | 0.04% | 312 |
|
2024
Q2 | $1.92M | Sell |
4,661
-1,844
| -28% | -$759K | 0.01% | 666 |
|
2024
Q1 | $2.63M | Sell |
6,505
-1,522
| -19% | -$615K | 0.01% | 602 |
|
2023
Q4 | $2.46M | Sell |
8,027
-11,893
| -60% | -$3.65M | 0.01% | 617 |
|
2023
Q3 | $4.82M | Buy |
19,920
+5,956
| +43% | +$1.44M | 0.03% | 408 |
|
2023
Q2 | $3.35M | Buy |
13,964
+10,940
| +362% | +$2.63M | 0.02% | 474 |
|
2023
Q1 | $569K | Sell |
3,024
-22,430
| -88% | -$4.22M | ﹤0.01% | 847 |
|
2022
Q4 | $5.41M | Sell |
25,454
-8,430
| -25% | -$1.79M | 0.03% | 342 |
|
2022
Q3 | $5.33M | Buy |
33,884
+2,115
| +7% | +$332K | 0.03% | 315 |
|
2022
Q2 | $4.76M | Buy |
31,769
+9,688
| +44% | +$1.45M | 0.03% | 321 |
|
2022
Q1 | $3.61M | Sell |
22,081
-3,110
| -12% | -$509K | 0.02% | 384 |
|
2021
Q4 | $5.48M | Buy |
25,191
+3,696
| +17% | +$804K | 0.03% | 322 |
|
2021
Q3 | $4.07M | Buy |
21,495
+12,185
| +131% | +$2.31M | 0.02% | 380 |
|
2021
Q2 | $1.64M | Buy |
+9,310
| New | +$1.64M | 0.01% | 581 |
|
2019
Q3 | – | Sell |
-85,425
| Closed | -$5.59M | – | 1038 |
|
2019
Q2 | $5.59M | Sell |
85,425
-12,031
| -12% | -$787K | 0.04% | 262 |
|
2019
Q1 | $5.75M | Sell |
97,456
-65,977
| -40% | -$3.89M | 0.04% | 259 |
|
2018
Q4 | $8.65M | Buy |
163,433
+41,762
| +34% | +$2.21M | 0.06% | 203 |
|
2018
Q3 | $7.29M | Buy |
121,671
+105,271
| +642% | +$6.31M | 0.04% | 255 |
|
2018
Q2 | $705K | Buy |
16,400
+7,925
| +94% | +$341K | ﹤0.01% | 695 |
|
2018
Q1 | $296K | Buy |
+8,475
| New | +$296K | ﹤0.01% | 620 |
|